TAKANASHI KEN enters SATSUMA PHARMACEUTICALS, INC. with 987.53K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 9/12/2019ACC: 0000899243-19-023453
Director10% Owner
Since Sep 2019
987.53K
Baseline shares
0.00
Direct ownership
0 positions
340.85K
Derivative underlying
2 instruments
1
Security positions
987.53K indirect
Non-Derivative Holdings1
Common Stock, $0.0001 par value
IndirectShares owned987.53K
Total
987.53K indirect987.53K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.0001 par value | 987.53K | Indirect |
| Total | 987.53K | 987.53K indirect |
Derivative Holdings2
Series B Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
307.11K
Shares owned
N/A
Exercise price
0.00
Expiration
—
Exercise window
—
Series A Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
33.74K
Shares owned
N/A
Exercise price
0.00
Expiration
—
Exercise window
—
Total
Underlying
340.85K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock | 0.00 | — | — | 307.11K | N/A |
| Series A Preferred Stock Indirect | Common Stock | 0.00 | — | — | 33.74K | N/A |
| Total | 340.85K | 0.00 | ||||